{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"data_sharing_plan":["IPD Sharing (as of June 2023): Yes\nDescription: The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: [contact information for Sponsor Investigator or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research\nTime frame: Data can be shared no earlier than 1 year following the date of publication\nAccess Criteria: MGH - Contact the Partners Innovations team at http://www.partners.org/innovation\nAdditional information available: Study Protocol, Statistical Analysis Plan, Informed Consent Form"],"condition":["Stage III Colorectal Cancer","Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Stage Iii Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2294315"],"location":["United States"],"study_start_month":["4"],"keyword":["Irinotecan","Nivolumab","Cetuximab","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer","description":"This research study is comparing two standard of care treatment options based on blood test results for participants who have metastatic colorectal cancer.\nThe names of the potential treatments involved in this study are:\n* Active surveillance\n* FOLFIRI treatment\n* Nivolumab treatment\n* Encorafenib/Binimetinib/Cetuximab treatment","dates":{"creation":"2020-04-15"},"accession":"2294315","cross_references":{"ClinicalTrials___gov":["NCT03803553"]}}